nerlynx
Generic: neratinib
nerlynx: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Approved |
FDA Decisions
Approval(PBYI)
Frequently asked questions
Who is developing nerlynx?
nerlynx is being developed by PUMA BIOTECHNOLOGY, INC..
What is nerlynx's latest FDA decision?
The most recent tracked FDA decision for nerlynx is Approval, dated July 17, 2017.
Get deeper analysis on nerlynx
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis